The prognosis for MDS varies widely based on several factors, including the specific subtype of MDS, the patient's age and overall health, and the presence of certain genetic mutations. Some patients may live many years with minimal symptoms, while others may experience rapidly progressing disease. The potential for progression to acute myeloid leukemia (AML) significantly impacts prognosis.
